|
Volumn 2, Issue 4, 1997, Pages 249-256
|
Single dose, dose-escalating trial with fozivudine tidoxil (BM 21.1290)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FOZIVUDINE TIDOXIL;
UNCLASSIFIED DRUG;
ZIDOVUDINE;
ZIDOVUDINE DERIVATIVE;
ZIDOVUDINE GLUCURONIDE;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG SAFETY;
DRUG TOLERABILITY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
ORAL DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
TABLET FORMULATION;
URINARY EXCRETION;
ADULT;
ANTI-HIV AGENTS;
FOOD;
HIV INFECTIONS;
HUMANS;
LIPIDS;
MALE;
MIDDLE AGED;
ZIDOVUDINE;
|
EID: 0031451851
PISSN: 13596535
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (5)
|